BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16554298)

  • 1. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin.
    Chandrasekar B; Mummidi S; Mahimainathan L; Patel DN; Bailey SR; Imam SZ; Greene WC; Valente AJ
    J Biol Chem; 2006 Jun; 281(22):15099-109. PubMed ID: 16554298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
    Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.
    Valente AJ; Yoshida T; Murthy SN; Sakamuri SS; Katsuyama M; Clark RA; Delafontaine P; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H282-96. PubMed ID: 22636674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
    Shyu KG; Chen SC; Wang BW; Cheng WP; Hung HF
    Clin Sci (Lond); 2012 Jan; 122(1):33-42. PubMed ID: 21806545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling.
    Chandrasekar B; Mummidi S; Valente AJ; Patel DN; Bailey SR; Freeman GL; Hatano M; Tokuhisa T; Jensen LE
    J Biol Chem; 2005 Jul; 280(28):26263-77. PubMed ID: 15890643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation.
    Reddy VS; Valente AJ; Delafontaine P; Chandrasekar B
    J Cell Physiol; 2011 Dec; 226(12):3303-15. PubMed ID: 21321938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-kappaB and AP-1 activation.
    Cheng G; Wei L; Xiurong W; Xiangzhen L; Shiguang Z; Songbin F
    Cell Mol Neurobiol; 2009 Dec; 29(8):1161-8. PubMed ID: 19404732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W; Dulak J; Frick M; Alber HF; Schwarzacher SP; Ares MP; Nilsson J; Pachinger O; Weidinger F
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):58-63. PubMed ID: 12524225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
    Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
    Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells.
    Lee EJ; Kim DI; Kim WJ; Moon SK
    Mol Nutr Food Res; 2009 Dec; 53(12):1582-91. PubMed ID: 19810018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.
    Venkatesan B; Valente AJ; Reddy VS; Siwik DA; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H874-86. PubMed ID: 19561311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
    Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
    Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple inhibitory activity of Cliona celata against TNF-α-induced matrix metalloproteinase-9 production via downregulated NF-κB and AP-1, enzyme activity, and migration potential.
    Suh SJ; Kwak CH; Song KH; Kwon KM; Chung TW; Cho SH; Kim YK; Yoon HD; Lee YC; Kim DS; Park SJ; Na MK; Son JK; Chang HW; Kim CH
    Inflammation; 2012 Apr; 35(2):736-45. PubMed ID: 21845471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases modulated by protein kinase Cε mediate resistin-induced migration of human coronary artery smooth muscle cells.
    Ding Q; Chai H; Mahmood N; Tsao J; Mochly-Rosen D; Zhou W
    J Vasc Surg; 2011 Apr; 53(4):1044-51. PubMed ID: 21277149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells.
    Lee CW; Lin CC; Lin WN; Liang KC; Luo SF; Wu CB; Wang SW; Yang CM
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L799-812. PubMed ID: 17158602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.
    Ariyoshi W; Okinaga T; Chaweewannakorn W; Akifusa S; Nisihara T
    J Cell Physiol; 2017 Dec; 232(12):3481-3495. PubMed ID: 28105703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.
    Ortego M; Bustos C; Hernández-Presa MA; Tuñón J; Díaz C; Hernández G; Egido J
    Atherosclerosis; 1999 Dec; 147(2):253-61. PubMed ID: 10559511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
    Shin WS; Hong Y; Lee HW; Lee ST
    Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways.
    Tseng HC; Lee IT; Lin CC; Chi PL; Cheng SE; Shih RH; Hsiao LD; Yang CM
    PLoS One; 2013; 8(3):e57955. PubMed ID: 23505448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.